These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 21364333)

  • 1. Minimum effective and relapse-associated doses of risperidone and olanzapine in aggressive, intellectually disabled adults.
    Janowsky DS; Hu Q; Buneviciute J; Davis JM
    J Clin Psychopharmacol; 2011 Apr; 31(2):238-40. PubMed ID: 21364333
    [No Abstract]   [Full Text] [Related]  

  • 2. Olanzapine vs. risperidone in treating aggressive behaviours in adults with intellectual disability: a single blind study.
    Amore M; Bertelli M; Villani D; Tamborini S; Rossi M
    J Intellect Disabil Res; 2011 Feb; 55(2):210-8. PubMed ID: 21129058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trial.
    Janowsky DS; Barnhill LJ; Davis JM
    J Clin Psychiatry; 2003 Oct; 64(10):1258-65. PubMed ID: 14658977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild Hypothermia in a Child with Low-Dose Risperidone.
    Grau K; Plener PL; Gahr M; Denzer C; Freudenmann RW
    Z Kinder Jugendpsychiatr Psychother; 2017 Jul; 45(4):335-337. PubMed ID: 27685194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical antipsychotic medication improves aggression, but not self-injurious behaviour, in adults with intellectual disabilities.
    Ruedrich SL; Swales TP; Rossvanes C; Diana L; Arkadiev V; Lim K
    J Intellect Disabil Res; 2008 Feb; 52(Pt 2):132-40. PubMed ID: 18197952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome with the addition of aripiprazole to olanzapine.
    Marshall PB; Mellman TA; Nguyen SX
    Am J Psychiatry; 2008 Nov; 165(11):1488-9. PubMed ID: 18981078
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience with Risperidone in the treatment of institutionalized mentally retarded patients, with special reference to treatment of aggressive states].
    Hal V; Fehér L
    Neuropsychopharmacol Hung; 2004 Mar; 6(1):19-25. PubMed ID: 15125310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brief report: effects of clozapine on self-injurious behavior of two risperidone nonresponders with mental retardation.
    Hammock R; Levine WR; Schroeder SR
    J Autism Dev Disord; 2001 Feb; 31(1):109-13. PubMed ID: 11439749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open-label treatment with risperidone of 26 psychiatrically-hospitalized children and adolescents with mixed diagnoses and aggressive behavior.
    Buitelaar JK
    J Child Adolesc Psychopharmacol; 2000; 10(1):19-26. PubMed ID: 10755578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimally effective doses of conventional antipsychotic medications used to treat aggression, self-injurious and destructive behaviors in mentally retarded adults.
    Janowsky DS; Barnhill LJ; Shetty M; Davis JM
    J Clin Psychopharmacol; 2005 Feb; 25(1):19-25. PubMed ID: 15643096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimum effective doses of haloperidol for the treatment of first psychotic episode: a comparative study with risperidone and olanzapine.
    Apiquian R; Fresán A; Herrera K; Ulloa RE; Lóyzaga C; de la Fuente-Sandoval C; Gutiérrez D; Nicolini H
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):403-8. PubMed ID: 14604455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possibilities and limits of treatment of aggressive behavior in patients with mental retardation with risperidone].
    Hässler F; Buchmann J; Bohne S
    Nervenarzt; 2002 Mar; 73(3):278-82. PubMed ID: 11963264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic response in first-episode schizophrenia: efficacy of high doses and switching.
    Agid O; Schulze L; Arenovich T; Sajeev G; McDonald K; Foussias G; Fervaha G; Remington G
    Eur Neuropsychopharmacol; 2013 Sep; 23(9):1017-22. PubMed ID: 23706529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone.
    Citrome L; Casey DE; Daniel DG; Wozniak P; Kochan LD; Tracy KA
    Psychiatr Serv; 2004 Mar; 55(3):290-4. PubMed ID: 15001730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of risperidone or olanzapine dose reduction on metabolic parameters, prolactin, and corrected QT interval in stable patients with schizophrenia.
    Takeuchi H; Suzuki T; Remington G; Watanabe K; Mimura M; Uchida H
    J Clin Psychopharmacol; 2014 Aug; 34(4):517-20. PubMed ID: 24911439
    [No Abstract]   [Full Text] [Related]  

  • 17. Risperidone-induced prolactin elevation in a prospective study of children, adolescents, and adults with mental retardation and pervasive developmental disorders.
    Hellings JA; Zarcone JR; Valdovinos MG; Reese RM; Gaughan E; Schroeder SR
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):885-92. PubMed ID: 16379508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and autism.
    Hellings JA; Zarcone JR; Crandall K; Wallace D; Schroeder SR
    J Child Adolesc Psychopharmacol; 2001; 11(3):229-38. PubMed ID: 11642473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated risperidone administration during puberty prevents the generation of the aggressive phenotype in a developmentally immature animal model of escalated aggression.
    Schwartzer JJ; Connor DF; Morrison RL; Ricci LA; Melloni RH
    Physiol Behav; 2008 Sep; 95(1-2):176-81. PubMed ID: 18617196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in Taiwan.
    Hsu WY; Huang SS; Lee BS; Chiu NY
    J Clin Psychopharmacol; 2010 Jun; 30(3):230-4. PubMed ID: 20473056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.